Inpatient Use of Metformin and Acarbose Is Associated with Reduced Mortality of COVID-19 Patients with Type 2 Diabetes Mellitus

Mostrar otras versiones (1)

Type 2 diabetes mellitus (T2DM) is a strong risk factor for complications of coronavirus disease 2019 (COVID-19). The effect of T2DM medications on COVID-19 outcomes remains unclear. In a retrospective analysis of a cohort of 131 patients with T2DM hospitalized for COVID-19 in Wuhan, we have previou...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Willis, Li, Jinghong, Wei, Qi, McCowen, Karen, Xiong, Wei, Liu, Jiao, Jiang, Wenlijun, Thomas, Robert, Hepokoski, Mark, He, Ming, Shyy, John, Malhotra, Atul, Xiong, Nian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010742/
https://www.ncbi.nlm.nih.gov/pubmed/33791691
http://dx.doi.org/10.21203/rs.3.rs-287308/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010742/
https://www.ncbi.nlm.nih.gov/pubmed/33791691
http://dx.doi.org/10.21203/rs.3.rs-287308/v1

Ejemplares similares